REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing…
LUXEMBOURG, April 20, 2026 /PRNewswire/ -- The European Data Protection Board (EDPB) took two major decisions that will facilitate international…
April 19, 2026 19:45 ET | Source: Sutro Biopharma, Inc. STRO-004 demonstrates robust and consistent antitumor activity across multiple TF-expressing…
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease…
RIGA, Latvia, April 15, 2026 /PRNewswire/ -- Today, Delska, one of the leading data center operators in the Baltics, officially…
Expanded program now includes coverage for operational data centers across the lifecycleDUBLIN, April 15, 2026 /PRNewswire/ -- Aon plc (NYSE: AON),…
April 15, 2026 01:00 ET | Source: BioVersys BASEL, Switzerland, April 15, 2026 (GLOBE NEWSWIRE) -- Poster presentations to feature…
Atlas replaces the fragmented outbound stack and delivers 8X industry reply rates — powered by continuously refreshed verified data across…
The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by 2030.PISCATAWAY, N.J. and LOS…
A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity over…